Blog
RSS FeedPosted by Michael Wonder on 01 Jun 2016
NICE to research patient preferences in HTA
1 June 2016 - Myeloma UK has awarded a health services research grant to NICE, to fund an exploratory study on ...
Posted by Michael Wonder on 01 Jun 2016
NICE asks company to put leukaemia drug forward for new Cancer Drugs Fund
1 June 2016 - NICE has published a second appraisal consultation document for ibrutinib for chronic lymphocytic leukaemia. ...
Posted by Michael Wonder on 26 May 2016
NICE issues draft guidance for necitumumab (Portrazza)
26 May 2016 - NICE has released an appraisal consulation document for necitumumab for untreated advanced or metastatic, squamous non-small-cell ...
Posted by Michael Wonder on 25 May 2016
NICE updates guidance on the use of cabazitaxel in patients with hormone-relapsed metastatic prostate cancer treated with docetaxel
24 May 2016 - This guidance replaces NICE technology appraisal guidance on the use of cabazitaxel in patients with hormone-refractory metastatic ...
Posted by Michael Wonder on 25 May 2016
NICE recommends three diabetes treatments
24 May 2016 - The three drugs can all be used on their own if a person can’t use metformin or ...
Posted by Michael Wonder on 20 May 2016
NICE recommends Novartis lung cancer drug Zykadia
20 May 2016 - NICE has recommended Novartis's Zykadia (ceritinib) for lung cancer in final guidance, after the manufacturer agreed to ...
Posted by Michael Wonder on 20 May 2016
Long term benefits of breast cancer drug pertuzumab too uncertain says NICE in draft guidance
20 May 2016 - NICE has today issued draft guidance not recommending pertuzumab (Perjeta, Roche) to treat HER2-positive breast cancer because ...
Posted by Michael Wonder on 12 May 2016
NICE turns down Opdivo for lung cancer
12 May 2016 - It is looking likely that patients with the most common form of lung cancer will not be ...
Posted by Michael Wonder on 11 May 2016
NICE backs NHS use of Benlysta, five years after EU nod
11 May 2016 - The first new drug for patients with lupus in more than 50 years could soon be available ...
Posted by Michael Wonder on 09 May 2016
NICE backs use of AbbVie's Humira for hidradenitis suppurativa
9 May 2016 - Final draft guidance not in accordance with HTA agencies in France & Australia. ...
Posted by Michael Wonder on 07 May 2016
NICE draft guidance recommends new drugs for cholesterol disorder
5 May 2016 - NICE has today published final draft guidance recommending 2 new treatment options for some people who have ...
Posted by Michael Wonder on 29 Apr 2016
NICE recommends combined drug therapy proven to extend life for skin cancer
29 April 2016 - NICE is today recommending a new drug combination for melanoma that could extend life by six months. ...
Posted by Michael Wonder on 27 Apr 2016
NICE & PBAC outcomes differ for new heart failure drug Entresto
27 April 2016 - Around 100,000 people in England and Wales could now benefit from treatment with Novartis’ revolutionary heart failure ...
Posted by Michael Wonder on 27 Apr 2016
NICE recommends ovarian cancer treatments
27 April 2016 - NICE has published final guidance for five ovarian cancer drugs. Three of the drugs are not recommended, ...
Posted by Michael Wonder on 25 Apr 2016
Drug prices: tweaking the formula
25 April 2016 - UK regulators are under pressure from Big Pharma as well as patients. ...